2-Aminothiazoles as therapeutic leads for prion diseases. Read more about 2-Aminothiazoles as therapeutic leads for prion diseases.
Heat shock protein 70 (hsp70) as an emerging drug target. Read more about Heat shock protein 70 (hsp70) as an emerging drug target.
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB. Read more about Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.
Divergent modes of enzyme inhibition in a homologous structure-activity series. Read more about Divergent modes of enzyme inhibition in a homologous structure-activity series.
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling. Read more about Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
Promiscuous aggregate-based inhibitors promote enzyme unfolding. Read more about Promiscuous aggregate-based inhibitors promote enzyme unfolding.
Synthesis and comparative toxicology of a series of polyhedral borane anion-substituted tetraphenyl porphyrins. Read more about Synthesis and comparative toxicology of a series of polyhedral borane anion-substituted tetraphenyl porphyrins.
Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. Read more about Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis.
Anilinodialkoxyquinazolines: screening epidermal growth factor receptor tyrosine kinase inhibitors for potential tumor imaging probes. Read more about Anilinodialkoxyquinazolines: screening epidermal growth factor receptor tyrosine kinase inhibitors for potential tumor imaging probes.
Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones. Read more about Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones.
